Amira buys SUPN 8.7: United Therapeutics : Supernus Receives $2 Million Milestone for United Therapeutics' Launch of Orenitram(TM)
ROCKVILLE, Md., May 20, 2014 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN) today announced that United Therapeutics Corporation (Nasdaq:UTHR) has paid Supernus a $2 million milestone payment under United Therapeutics' license agreement . ... ...
25 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home